These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1653630)

  • 41. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K; Kohno K; Takano H; Sato S; Kiue A; Kuwano M
    Cancer Res; 1990 Sep; 50(18):5819-24. PubMed ID: 2168282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subcellular distribution of the alpha and beta topoisomerase II-DNA complexes stabilized by VM-26.
    Danks MK; Qiu J; Catapano CV; Schmidt CA; Beck WT; Fernandes DJ
    Biochem Pharmacol; 1994 Nov; 48(9):1785-95. PubMed ID: 7980648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of nucleosomes and anti-tumor drugs on the catalytic activity of type II DNA topoisomerase from rat testis.
    Galande S; Muniyappa K
    Biochem Pharmacol; 1997 May; 53(9):1229-38. PubMed ID: 9214683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA topoisomerase II isozymes involved in anticancer drug action and resistance.
    Fernandes DJ; Qiu J; Catapano CV
    Adv Enzyme Regul; 1995; 35():265-81. PubMed ID: 7572348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.
    Beck WT
    J Natl Cancer Inst; 1989 Nov; 81(22):1683-5. PubMed ID: 2553990
    [No Abstract]   [Full Text] [Related]  

  • 46. Yeast DNA topoisomerase II. An ATP-dependent type II topoisomerase that catalyzes the catenation, decatenation, unknotting, and relaxation of double-stranded DNA rings.
    Goto T; Wang JC
    J Biol Chem; 1982 May; 257(10):5866-72. PubMed ID: 6279616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.
    Danks MK; Schmidt CA; Cirtain MC; Suttle DP; Beck WT
    Biochemistry; 1988 Nov; 27(24):8861-9. PubMed ID: 2853972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
    Thielmann HW; Popanda O; Gersbach H; Gilberg F
    Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?
    Bax BD; Sutormin D; McDonald NQ; Burley GA; Shelkovnikova T
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors.
    Wolverton JS; Danks MK; Granzen B; Beck WT
    Cancer Res; 1992 Aug; 52(15):4248-53. PubMed ID: 1322239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
    Andoh T; Ishii K; Suzuki Y; Ikegami Y; Kusunoki Y; Takemoto Y; Okada K
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5565-9. PubMed ID: 3039492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A DNA topoisomerase from trypanosomes able to catenate, decatenate and unknot DNA without ATP].
    Douc-Rasy S; Riou JF; Kayser A; Riou G
    C R Acad Sci III; 1986; 302(8):283-6. PubMed ID: 3011222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iridoids as DNA topoisomerase I poisons.
    Gálvez M; Martín-Cordero C; Ayuso MJ
    J Enzyme Inhib Med Chem; 2005 Aug; 20(4):389-92. PubMed ID: 16206835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA-unwinding test using eukaryotic DNA topoisomerase I.
    Shen LL
    Methods Mol Biol; 2001; 95():149-60. PubMed ID: 11089228
    [No Abstract]   [Full Text] [Related]  

  • 55. Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells.
    Singh SP; Mohamed R; Salmond C; Lavin MF
    Nucleic Acids Res; 1988 May; 16(9):3919-29. PubMed ID: 2836804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.
    Woessner RD; Chung TD; Hofmann GA; Mattern MR; Mirabelli CK; Drake FH; Johnson RK
    Cancer Res; 1990 May; 50(10):2901-8. PubMed ID: 2159365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells.
    Friche E; Danks MK; Schmidt CA; Beck WT
    Cancer Res; 1991 Aug; 51(16):4213-8. PubMed ID: 1678312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
    Utsugi T; Mattern MR; Mirabelli CK; Hanna N
    Cancer Res; 1990 May; 50(9):2636-40. PubMed ID: 2158396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GTP induces knotting, catenation, and relaxation of DNA by stoichiometric amounts of DNA topoisomerase II from Bombyx mori and HeLa cells.
    Hirose S; Tabuchi H; Yoshinaga K
    J Biol Chem; 1988 Mar; 263(8):3805-10. PubMed ID: 2831204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plant and Human MORC Proteins Have DNA-Modifying Activities Similar to Type II Topoisomerases, but Require One or More Additional Factors for Full Activity.
    Manohar M; Choi HW; Manosalva P; Austin CA; Peters JE; Klessig DF
    Mol Plant Microbe Interact; 2017 Feb; 30(2):87-100. PubMed ID: 27992291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.